Fairvalue-Calculator Fairvalue-Calculator
EN DE

Laseroptek Co (199550) Fair Value & Analysis

Healthcare · KR · Market cap 55.4B KRW

Price3,295 KRW
Fair Value4,483 KRW
Upside+36.1%
Quality95/100
Evidence: Low Range 3,362 KRW – 5,604 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Laseroptek Co (199550) currently trades at 3,295 KRW, while our model-based Fair Value estimate is 4,483 KRW — implying the stock looks roughly 36.1% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Laseroptek Co., Ltd. develops and manufactures aesthetic and medical laser devices in South Korea. Its laser devices perform aesthetic and medical dermatological treatments for a range of indications, such as benign pigmentation lesions, fine lines and wrinkles, scar revision, skin rejuvenation and lifting, hair removal, vascular lesions, vitiligo, psoriasis, atopic dermatitis, leukoderma, and alopecia areata. The company was founded in 2000 and is based in Seongnam-si, South Korea.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Laseroptek Co (199550) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 4,483 KRW versus a price of 3,295 KRW — about +36% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 199550?
Our 21-model fair value for Laseroptek Co is 4,483 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 3,295 KRW.
What is the quality score of 199550?
Laseroptek Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.